{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:36:07Z","timestamp":1791318967283,"version":"4.3.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.revmed.2004.01.012","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T06:41:51Z","timestamp":1078555311000},"page":"636-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Les glucocortico\u00efdes et leur r\u00e9cepteur\u00a0: m\u00e9canismes d'action et cons\u00e9quences cliniques"],"prefix":"10.1016","volume":"25","author":[{"given":"C.","family":"Roumestan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gougat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaffuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2004.01.012_BIB1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.revmed.2004.01.012_BIB2","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1210\/endo.143.7.8892","article-title":"Minireview: nuclear receptor coactivators-an update","volume":"143","author":"McKenna","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.revmed.2004.01.012_BIB3","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/j.1460-2075.1994.tb06726.x","article-title":"A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1","volume":"13","author":"Heck","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB4","first-page":"1016","article-title":"Mutation\/polymorphism scanning of glucose-6-phosphatase gene promoter in noninsulin-dependent diabetes mellitus patients","volume":"83","author":"Yoshiuchi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2004.01.012_BIB5","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1016\/S0021-9258(18)53327-5","article-title":"Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids","volume":"268","author":"Imai","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0092-8674(87)90752-5","article-title":"Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene","volume":"49","author":"Jantzen","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.01.012_BIB7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/bj3430687","article-title":"Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I","volume":"3","author":"Beurton","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ki.1996.291","article-title":"\u03b2-adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells","volume":"50","author":"Ming","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2004.01.012_BIB9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.RES.77.2.249","article-title":"Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter","volume":"77","author":"Guo","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.revmed.2004.01.012_BIB10","doi-asserted-by":"crossref","first-page":"12431","DOI":"10.1074\/jbc.274.18.12431","article-title":"Glucocorticoid induction of epithelial sodium channel expression in lung and renal epithelia occurs via trans-activation of a hormone response element in the 5\u2019-flanking region of the human epithelial sodium channel alpha subunit gene","volume":"274","author":"Sayegh","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB11","doi-asserted-by":"crossref","first-page":"E971","DOI":"10.1152\/ajpendo.00021.2002","article-title":"Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5\u2019-flanking region","volume":"283","author":"Itani","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.revmed.2004.01.012_BIB12","first-page":"L319","article-title":"Identification of glucocorticoid-responsive elements that control transcription of rat glutamine synthetase","volume":"276","author":"Chandrasekhar","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB13","first-page":"E1136","article-title":"Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms","volume":"276","author":"Labow","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB14","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1210\/endo.142.4.8082","article-title":"Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I","volume":"142","author":"Brink","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.revmed.2004.01.012_BIB15","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1074\/jbc.273.11.6341","article-title":"Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells","volume":"273","author":"Nguyen","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB16","first-page":"505","article-title":"Adverse effects of corticosteroids on the cardiovascular system","volume":"16","author":"Sholter","year":"2000","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB17","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1073\/pnas.84.20.6995","article-title":"Structure of the gene for human \u03b22-adrenergic receptor: expression and promoter characterization","volume":"84","author":"Emorine","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.01.012_BIB18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1164\/ajrccm.153.5.8630590","article-title":"Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids","volume":"153","author":"Woolcock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2004.01.012_BIB19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.revmed.2004.01.012_BIB20","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/278456a0","article-title":"Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation","volume":"278","author":"Flower","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2004.01.012_BIB21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0005-2760(82)90100-X","article-title":"Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor","volume":"712","author":"Russo-Marie","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.revmed.2004.01.012_BIB22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1126\/science.270.5234.286","article-title":"Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of I kappaB synthesis","volume":"270","author":"Auphan","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.01.012_BIB23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/blood-2002-02-0538","article-title":"Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL10","volume":"101","author":"Berrebi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2004.01.012_BIB24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/mend-2-8-732","article-title":"Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids","volume":"2","author":"Bronnegard","year":"1988","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB25","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1016\/S0021-9258(18)83381-6","article-title":"Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1\u00a0as the second messenger","volume":"264","author":"Bienkowski","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB26","doi-asserted-by":"crossref","first-page":"19612","DOI":"10.1074\/jbc.271.32.19612","article-title":"Glucocorticoid-mediated repression of NF-kappaB activity in endothelial cells does not involve induction of I kappaB alpha synthesis","volume":"271","author":"Brostjan","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB27","doi-asserted-by":"crossref","first-page":"13504","DOI":"10.1073\/pnas.94.25.13504","article-title":"Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation","volume":"94","author":"De Bosscher","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.01.012_BIB28","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1093\/emboj\/16.15.4698","article-title":"I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor","volume":"16","author":"Heck","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1083\/jcb.147.7.1365","article-title":"The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin","volume":"147","author":"Tuckermann","year":"1999","journal-title":"J Cell Biol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB30","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1093\/emboj\/20.24.7168","article-title":"Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor","volume":"20","author":"Reichardt","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1096\/fj.02-0239fje","article-title":"Aberrant inflammation and resistance to glucocorticoids in annexin 1-\/- mouse","volume":"17","author":"Hannon","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/bj20021856","article-title":"Attenuation of glucocorticoid functions in an Anx-A1-\/- cell line","volume":"371","author":"Croxtall","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.bjp.0703272","article-title":"Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism","volume":"130","author":"Croxtall","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/en.2002-220592","volume":"144","author":"Solito","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.revmed.2004.01.012_BIB35","doi-asserted-by":"crossref","first-page":"30709","DOI":"10.1074\/jbc.272.49.30709","article-title":"A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene","volume":"272","author":"Meyer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/bies.950180507","article-title":"Molecular mechanisms of anti-inflammatory action of glucocorticoids","volume":"18","author":"Cato","year":"1996","journal-title":"Bioessays"},{"key":"10.1016\/j.revmed.2004.01.012_BIB37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/thx.53.7.601","article-title":"Role of transcription factors in inflammatory lung diseases","volume":"53","author":"Rahman","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.revmed.2004.01.012_BIB38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1098\/rstb.1996.0008","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"351","author":"Karin","year":"1996","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.revmed.2004.01.012_BIB39","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/370226a0","article-title":"Activation of cAMP and mitogen responsive genes relies on a common nuclear factor","volume":"370","author":"Arias","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.revmed.2004.01.012_BIB40","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1097-2765(02)00477-X","article-title":"The phosphorylation status of nuclear NF-kappa B determines its association with CBP\/p300 or HDAC-1","volume":"9","author":"Zhong","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.revmed.2004.01.012_BIB41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0006-291X(02)02932-7","article-title":"Phosphorylation of serine 276\u00a0is essential for p65 NF-kappaB subunit-dependent cellular responses","volume":"300","author":"Okazaki","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.revmed.2004.01.012_BIB42","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/j.1460-2075.1995.tb07287.x","article-title":"Phosphorylation of human I kappa B-alpha on serines 32\u00a0and 36\u00a0controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli","volume":"14","author":"Traenckner","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB43","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/j.1460-2075.1992.tb05283.x","article-title":"Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo","volume":"11","author":"Konig","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB44","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1101\/gad.827900","article-title":"The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain","volume":"14","author":"Nissen","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.revmed.2004.01.012_BIB45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1083\/jcb.150.5.1199","article-title":"Glucocorticoids antagonize AP-1 by inhibiting the Activation\u2013phosphorylation of JNK without affecting its subcellular distribution","volume":"150","author":"Gonzalez","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB46","doi-asserted-by":"crossref","first-page":"21467","DOI":"10.1074\/jbc.272.34.21467","article-title":"A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation","volume":"272","author":"Liden","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(98)00208-1","article-title":"Glucocorticoid signalling-multiple variations of a common theme","volume":"146","author":"Reichardt","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB48","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1038\/sj.onc.1204388","article-title":"Cross-talk between glucocorticoid receptor and AP-1","volume":"20","author":"Herrlich","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.revmed.2004.01.012_BIB49","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1074\/jbc.275.2.1321","article-title":"Regulation of the rat serotonin-1A receptor gene by corticosteroids","volume":"275","author":"Wissink","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB50","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1128\/MCB.17.10.5952","article-title":"Antagonism between Nur77 and glucocorticoid receptor for control of transcription","volume":"17","author":"Philips","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB51","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1210\/mend.13.10.0351","article-title":"Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene","volume":"13","author":"Malkoski","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/mend.11.1.9874","article-title":"Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1\/nur77 subfamily of nuclear receptors","volume":"11","author":"Murphy","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/mend-5-1-100","article-title":"Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators","volume":"5","author":"Chatterjee","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB54","first-page":"527","article-title":"Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells","volume":"4","author":"Stauber","year":"1992","journal-title":"N. Biol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB55","doi-asserted-by":"crossref","first-page":"11776","DOI":"10.1073\/pnas.96.21.11776","article-title":"Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3","volume":"96","author":"Song","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.revmed.2004.01.012_BIB56","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O","article-title":"Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta","volume":"183","author":"Chen","year":"2000","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB57","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1126\/science.2119054","article-title":"Transcription factor interactions: selectors of positive or negative regulation from a single DNA element","volume":"249","author":"Diamond","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.revmed.2004.01.012_BIB58","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1016\/S0021-9258(17)38555-1","article-title":"Pretranslational regulation of type I collagen, fibronectin, and a 50-kilodalton noncollagenous extracellular protein by dexamethasone in rat fibroblasts","volume":"261","author":"Raghow","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.revmed.2004.01.012_BIB59","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1084\/jem.173.2.349","article-title":"The AU-rich sequences in the 3\u2019 untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids","volume":"173","author":"Peppel","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2004.01.012_BIB60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V79.1.45.45","article-title":"Glucocorticoids downregulate gene expression of GM-CSF, NAP-1\/IL-8, and IL-6, but not of M-CSF in human fibroblasts","volume":"79","author":"Tobler","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2004.01.012_BIB61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1677\/joe.0.0550489","article-title":"Characteristics of fast feedback control of corticotrophin release by corticosteroids","volume":"55","author":"Jones","year":"1972","journal-title":"J Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB62","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1101\/gad.9.13.1608","article-title":"Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation","volume":"9","author":"Cole","year":"1995","journal-title":"Genes Dev"},{"key":"10.1016\/j.revmed.2004.01.012_BIB63","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(00)81183-6","article-title":"DNA binding of the glucocorticoid receptor is not essential for survival","volume":"93","author":"Reichardt","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.01.012_BIB64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/mol.62.2.297","article-title":"trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y 1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB65","first-page":"357","article-title":"SEGRAs: a novel class of anti-inflammatory compounds","volume":"2002","author":"Schacke","year":"2002","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.revmed.2004.01.012_BIB66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0039-128X(94)00067-M","article-title":"Molecular identification of steroid analogs with dissociated antiprogestin activities","volume":"60","author":"Wehle","year":"1995","journal-title":"Steroids"},{"key":"10.1016\/j.revmed.2004.01.012_BIB67","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/mend.11.9.9979","article-title":"Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo","volume":"11","author":"Vayssiere","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB68","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0026-895X(24)12543-6","article-title":"Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism","volume":"56","author":"Vanden Berghe","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB69","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.4049\/jimmunol.166.3.1975","article-title":"Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity","volume":"166","author":"Belvisi","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(96)03339-9","article-title":"Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate","volume":"348","author":"Todd","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2004.01.012_BIB71","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.317.7171.1491","article-title":"High dose inhaled corticosteroids and dose dependent loss of diabetic control","volume":"317","author":"Faul","year":"1998","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1183\/09031936.99.141","article-title":"Deteriorating diabetic control associated with high-dose inhaled budesonide","volume":"14","author":"Faul","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2004.01.012_BIB73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1378\/chest.117.2.593","article-title":"Asthma and Cushing\u2019s syndrome","volume":"117","author":"Wilson","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2004.01.012_BIB74","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(90)90395-U","article-title":"Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos\/Jun) activity by glucocorticoid hormone","volume":"62","author":"Jonat","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2004.01.012_BIB75","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/MCB.15.2.1005","article-title":"Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors","volume":"15","author":"Liu","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/ajrccm.162.1.9901006","article-title":"Transcriptional potencies of inhaled glucocorticoids","volume":"162","author":"Jaffuel","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2004.01.012_BIB77","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2222.2003.01709.x","article-title":"Fluticasone propionate and mometasone furoate have equivalent transcriptional potencies","volume":"33","author":"Roumestan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.revmed.2004.01.012_BIB78","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes. A report of 14\u00a0cases and a review of the literature","volume":"5","author":"Lewis","year":"1983","journal-title":"J Affect Disord"},{"key":"10.1016\/j.revmed.2004.01.012_BIB79","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1378\/chest.122.2.624","article-title":"Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids","volume":"122","author":"Kayani","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2004.01.012_BIB80","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0091-6749(85)90708-0","article-title":"Steroid myopathy: incidence and detection in a population with asthma","volume":"76","author":"Bowyer","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB81","first-page":"1191","article-title":"Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia","volume":"19","author":"Porges","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2004.01.012_BIB82","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1191\/0961203302lu243oa","article-title":"Low-dose pulse methylprednisolone for systemic lupus erythematosus flares is efficacious and has a decreased risk of infectious complications","volume":"11","author":"Badsha","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2004.01.012_BIB83","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1529-0131(200110)45:5<462::AID-ART366>3.0.CO;2-V","article-title":"Resolved: Low-dose prednisone is indicated as a standard treatment in patients with rheumatoid arthritis","volume":"45","author":"Conn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2004.01.012_BIB84","first-page":"1","article-title":"The use of low-dose prednisone in the management of rheumatoid arthritis","volume":"50","author":"Lim","year":"2001","journal-title":"Bull Rheum Dis"},{"key":"10.1016\/j.revmed.2004.01.012_BIB85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events","volume":"96","author":"Saag","year":"1994","journal-title":"Am J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304000530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304000530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:08:19Z","timestamp":1759334899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866304000530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0248866304000530"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2004.01.012","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les glucocortico\u00efdes et leur r\u00e9cepteur\u00a0: m\u00e9canismes d'action et cons\u00e9quences cliniques","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2004.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}